Section Pathology

Anne-Laure Rougemont-Pidoux
President SAKK Section Pathology
President Section Pathology



The section of pathology aims to design and conduct translational research in the field of clinical trials. It functions as a platform to promote multicenter trials in the pathology community. Further, the section is active in the following areas:

  • Quality assurance of clinical trials regarding pathology diagnoses;
  • Review of initial pathology diagnose for quality assurance;
  • Establishment of novel predictive tests, for example PIK3CA for Cetuximab treatment or NRAS-testing Vemurafenib treatment in Melanoma;
  • Translational research requires tissue banking; pathologists are involved in the establishment of biobanks and collection of biomaterial.


  • Development of pathology-based clinical trials;
  • Involvement of pathologists in the early phases of protocol development;
  • Information on SAKK activities involving pathology investigations and translational research to the pathology community.